Back to All Events

AACR Conference on Pancreatic Cancer: New Frontiers in Biology and Therapeutic Development


  • Hilton San Diego Bayfront 1 Park Boulevard San Diego, California, 92101 United States (map)

Event Details

Dates: September 25 to 28, 2026

Location: Hilton San Diego Bayfront, 1 Park Blvd, San Diego, California

Event Website: https://www.aacr.org/meeting/aacr-conference-on-pancreatic-cancer/

Event Overview

Cizzle Bio will attend the AACR Conference on Pancreatic Cancer: New Frontiers in Biology and Therapeutic Development, a specialized scientific meeting bringing together a global community of researchers, clinicians, translational scientists, and industry leaders focused on advancing pancreatic cancer research and patient care.

Hosted by the American Association for Cancer Research (AACR), the conference will explore rapidly evolving areas of pancreatic cancer science, including early detection and interception, precision oncology, KRAS-targeted therapeutics, immunotherapy, AI and multi-omics, tumor biology, clinical trials, and translational research.

The program is designed to connect scientific discovery with clinical impact, creating opportunities for collaboration across academia, biotechnology, pharmaceutical development, and cancer care.

Why Attend

  • Explore advances in early pancreatic cancer detection and interception.

  • Gain insight into emerging research in precision oncology, KRAS-targeted therapies, immunotherapy, AI, and multi-omics.

  • Learn from leading researchers, clinicians, and translational scientists working to improve pancreatic cancer outcomes.

  • Engage with a multidisciplinary community focused on translating scientific discovery into meaningful clinical progress.

Cizzle Bio's Focus

As a company dedicated to advancing biomarker blood tests for early cancer detection, Cizzle Bio values scientific forums that explore new approaches to detecting and understanding cancer at its earliest stages.

Attendance at the AACR Conference on Pancreatic Cancer supports our commitment to staying engaged with advances in early detection, biomarker science, precision oncology, and translational research, while connecting with the scientific community working to improve outcomes for patients with difficult-to-detect cancers.

 
Previous
Previous
September 22

Oracle Health and Life Sciences Summit 2026

Next
Next
October 7

2026 AVBCC Summit